ASSURE Wearable ECG vs cvi42 Auto Imaging

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Kestra Medical Technologies
VS
by Circle Cardiovascular Imaging Inc.

AI Verdict

Tool A focuses on continuous, real-time heart rate monitoring and data collection via a wearable device for at-risk cardiac patients. In contrast, Tool B is an AI-powered software designed for comprehensive analysis of cardiovascular MR and CT images to aid in precise diagnosis and plaque quantification. Therefore, while both contribute to cardiology, they serve distinct purposes: one for ongoing remote patient monitoring and the other for in-depth diagnostic imaging analysis.

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you require continuous, real-time heart rate monitoring and automatic event detection for at-risk cardiac patients in an outpatient setting. This wearable device and integrated platform are ideal for proactive remote patient monitoring, enabling early intervention through alert-based notifications and physiologic trend data review by clinicians.

View ASSURE Wearable ECG →

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if your primary need is comprehensive, AI-powered analysis of cardiovascular MR and CT images for precise diagnosis, plaque quantification, and treatment planning. This software excels at quantitative assessment of cardiac function, tissue characterization, and vascular conditions, streamlining complex imaging workflows for radiologists and cardiologists.

View cvi42 Auto Imaging →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature ASSURE Wearable ECG cvi42 Auto Imaging
Pricing Unknown Starts at $5000 per license
Deployment The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. On-premise (standalone workstation or client/server)
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool A, the ASSURE Wearable ECG, is designed with a strong emphasis on patient comfort and ease of use, featuring an 'intuitive' mobile application and a 'SensorFit Garment' with cushioned sensors for continuous wear. Its 'Empathy Powered Designu2122' prioritizes reducing false alarms and improving comfort, which is crucial for patient adherence to a wearable device.

Clinical Value

cvi42 Auto Imaging

Tool B, cvi42 Auto Imaging, offers comprehensive AI-powered analysis of cardiovascular MR and CT images, enabling precise diagnosis, plaque quantification, and advanced vascular analysis across multiple modalities. This provides deeper diagnostic insights for complex conditions, directly impacting treatment planning and patient management. While Tool A provides critical continuous monitoring and therapeutic intervention, Tool B's capabilities offer a broader and more detailed diagnostic picture from advanced imaging.

Pricing & Value

cvi42 Auto Imaging

Both tools require direct contact for pricing, making a direct cost comparison difficult. However, Tool B explicitly mentions a flexible subscription model that scales across service lines and highlights the availability of new Category I CPT codes for AI-enabled coronary plaque analysis, which can facilitate reimbursement and enhance its overall value proposition for healthcare providers.

Enterprise Readiness

ASSURE Wearable ECG

Tool A explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), alongside its cloud-based remote patient data platform. This clear articulation of compliance and a well-defined cloud infrastructure makes it more straightforward for enterprise integration, particularly for remote patient monitoring.

Innovation

cvi42 Auto Imaging

Tool B demonstrates significant innovation in applying AI to complex cardiovascular imaging for automated segmentation, precise plaque quantification, and multi-modality support (MR, CT, Vascular CT). Its AI-driven vascular analysis and virtual device simulation for procedural planning represent a broader and deeper advancement in diagnostic and interventional cardiology.

Support & Docs

cvi42 Auto Imaging

Tool B provides expert technical support, a dedicated helpline, and extensive online documentation including user manuals and DICOM conformance statements. Furthermore, it boasts 'industry-leading Net Promoter Score (NPS) and Customer Satisfaction (CSAT) feedback scores,' indicating a highly effective and well-regarded support system for its professional users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature ASSURE Wearable ECG cvi42 Auto Imaging
Name ASSURE Wearable ECG cvi42 Auto Imaging
Company Kestra Medical Technologies Circle Cardiovascular Imaging
Description A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows.
Categories Cardiology AI, Wearables & Remote Monitoring (RPM) Cardiology AI, Radiology & Imaging AI
Specialties Cardiology Cardiology, Radiology, Vascular Surgery
Key Features (Partial) Wearable ECG device for continuous heart rate monitoring, SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors, ASSURE Detection Algorithm with Quad Channel Processingu2122, Adaptive Patient Intelligenceu2122 for filtering motion artifacts, Automatic episode storage, Alert-based notifications, Physiologic trend data, Kestra CareStation remote patient data platform for clinician review AI-enabled automated contouring and segmentation, Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain), Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment), Vascular CT analysis (diagnosis, planning, surveillance), Quantitative analysis (volume, mass, function, signal intensity, plaque), 3D visualization and multiplanar reconstruction (MPR), Simplified and smart reporting with infographics and CAD-RADS classification, Multi-modality support (MR, CT) and vendor-neutral compatibility

Videos

Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and cvi42 Auto Imaging.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Tool A, ASSURE Wearable ECG, is a non-therapeutic wearable device for continuous heart rate monitoring and ECG data collection for at-risk cardiac patients. Tool B, cvi42 Auto Imaging, is an AI-powered software designed for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis and plaque quantification.
ASSURE Wearable ECG utilizes its ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligenceu2122 to filter motion artifacts and automatically store cardiac episodes. cvi42 Auto Imaging employs AI for automated contouring and segmentation, enabling comprehensive quantitative analysis of cardiac MR and CT images, including plaque assessment and strain analysis.
ASSURE Wearable ECG is primarily designed for Cardiology. cvi42 Auto Imaging supports a broader range of specialties including Cardiology, Radiology, and Vascular Surgery.

Backers

Who funded each tool's parent company.

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.